Literature DB >> 21901585

Cell-based therapy for neural disorders--anticipating challenges.

Arlene Y Chiu1, Mahendra S Rao.   

Abstract

Neurological syndromes, such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, Huntington's disease, amyotrophic lateral sclerosis, and lysosomal storage disorders, such as Battens disease, are devastating because they result in increasing loss of cognitive and physical function. Sadly, no drugs are currently available to halt their progression. The relative paucity of curative approaches for these and other conditions of the nervous system have led to a widespread evaluation of alternative treatment modalities including cell-based interventions. Several cell types have been tested successfully in animal models where safety and efficacy have been demonstrated. Early clinical trials have also been initiated in humans, and some have shown a degree of success albeit on a more limited scale than in animal experiments. Recent demonstrations that pluripotent stem cells, such as embryonic stem cells and induced pluripotent stem cells, can differentiate into a variety of specific neural phenotypes has stimulated worldwide enthusiasm for developing cell-based intervention of neurological disease. Indeed, several groups are preparing investigational new drug applications to treat disorders as diverse as macular degeneration, lysosomal storage diseases, and Parkinson's disease. It is noteworthy that cell replacement therapies for neurological conditions face key challenges, some of which are unique, because of the development and organization of the nervous system, its metabolism, and connectivity. Choice of the cell (or cells), the process of manufacturing them, defining the delivery pathway, developing and testing in an appropriate preclinical model, selecting a patient population, and visualizing and following or monitoring patients all pose specific issues as related to the central and peripheral nervous systems. In this review, we address a myriad of challenges that are solvable, but require careful planning and attention to the special demands of the human nervous system.

Entities:  

Mesh:

Year:  2011        PMID: 21901585      PMCID: PMC3250286          DOI: 10.1007/s13311-011-0066-9

Source DB:  PubMed          Journal:  Neurotherapeutics        ISSN: 1878-7479            Impact factor:   7.620


  27 in total

1.  Genomic alterations in cultured human embryonic stem cells.

Authors:  Anirban Maitra; Dan E Arking; Narayan Shivapurkar; Morna Ikeda; Victor Stastny; Keyaunoosh Kassauei; Guoping Sui; David J Cutler; Ying Liu; Sandii N Brimble; Karin Noaksson; Johan Hyllner; Thomas C Schulz; Xianmin Zeng; William J Freed; Jeremy Crook; Suman Abraham; Alan Colman; Peter Sartipy; Sei-Ichi Matsui; Melissa Carpenter; Adi F Gazdar; Mahendra Rao; Aravinda Chakravarti
Journal:  Nat Genet       Date:  2005-09-04       Impact factor: 38.330

Review 2.  Mechanisms of neural plasticity following brain injury.

Authors:  Tadeusz Wieloch; Karoly Nikolich
Journal:  Curr Opin Neurobiol       Date:  2006-05-18       Impact factor: 6.627

Review 3.  Conserved and divergent paths that regulate self-renewal in mouse and human embryonic stem cells.

Authors:  Mahendra Rao
Journal:  Dev Biol       Date:  2004-11-15       Impact factor: 3.582

Review 4.  Cell therapy in Parkinson's disease.

Authors:  Olle Lindvall; Anders Björklund
Journal:  NeuroRx       Date:  2004-10

5.  Disease progression of human SOD1 (G93A) transgenic ALS model rats.

Authors:  Arifumi Matsumoto; Yohei Okada; Masanori Nakamichi; Masaya Nakamura; Yoshiaki Toyama; Gen Sobue; Makiko Nagai; Masashi Aoki; Yasuto Itoyama; Hideyuki Okano
Journal:  J Neurosci Res       Date:  2006-01       Impact factor: 4.164

6.  Direct conversion of human fibroblasts to dopaminergic neurons.

Authors:  Ulrich Pfisterer; Agnete Kirkeby; Olof Torper; James Wood; Jenny Nelander; Audrey Dufour; Anders Björklund; Olle Lindvall; Johan Jakobsson; Malin Parmar
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-06       Impact factor: 11.205

Review 7.  Human embryonic stem cells: long term stability, absence of senescence and a potential cell source for neural replacement.

Authors:  X Zeng; M S Rao
Journal:  Neuroscience       Date:  2006-10-19       Impact factor: 3.590

8.  Homologous recombination in human embryonic stem cells.

Authors:  Thomas P Zwaka; James A Thomson
Journal:  Nat Biotechnol       Date:  2003-02-10       Impact factor: 54.908

9.  Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation.

Authors:  M E Gurney; H Pu; A Y Chiu; M C Dal Canto; C Y Polchow; D D Alexander; J Caliendo; A Hentati; Y W Kwon; H X Deng
Journal:  Science       Date:  1994-06-17       Impact factor: 47.728

Review 10.  The morphogenesis of evolutionary developmental biology.

Authors:  Scott F Gilbert
Journal:  Int J Dev Biol       Date:  2003       Impact factor: 2.203

View more
  18 in total

Review 1.  G-protein-coupled receptors in adult neurogenesis.

Authors:  Van A Doze; Dianne M Perez
Journal:  Pharmacol Rev       Date:  2012-05-18       Impact factor: 25.468

Review 2.  The pharmacology of regenerative medicine.

Authors:  George J Christ; Justin M Saul; Mark E Furth; Karl-Erik Andersson
Journal:  Pharmacol Rev       Date:  2013-07-01       Impact factor: 25.468

3.  Screening of bioactive peptides using an embryonic stem cell-based neurodifferentiation assay.

Authors:  Ruodan Xu; Maxime Feyeux; Stéphanie Julien; Csilla Nemes; Morten Albrechtsen; Andras Dinnyés; Karl-Heinz Krause
Journal:  AAPS J       Date:  2014-02-21       Impact factor: 4.009

Review 4.  Stem cell therapies in age-related neurodegenerative diseases and stroke.

Authors:  Yuan Wang; Xunming Ji; Rehana K Leak; Fenghua Chen; Guodong Cao
Journal:  Ageing Res Rev       Date:  2016-11-19       Impact factor: 10.895

5.  Human dental stem cell derived transgene-free iPSCs generate functional neurons via embryoid body-mediated and direct induction methods.

Authors:  Ikbale El Ayachi; Jun Zhang; Xiao-Ying Zou; Dong Li; Zongdong Yu; Wei Wei; Kristen M S O'Connell; George T-J Huang
Journal:  J Tissue Eng Regen Med       Date:  2018-01-17       Impact factor: 3.963

Review 6.  Glial progenitor cell-based treatment of the childhood leukodystrophies.

Authors:  M Joana Osorio; Steven A Goldman
Journal:  Exp Neurol       Date:  2016-05-08       Impact factor: 5.330

7.  Engineered Axonal Tracts as "Living Electrodes" for Synaptic-Based Modulation of Neural Circuitry.

Authors:  Mijail D Serruya; James P Harris; Dayo O Adewole; Laura A Struzyna; Justin C Burrell; Ashley Nemes; Dmitriy Petrov; Reuben H Kraft; H Isaac Chen; John A Wolf; D Kacy Cullen
Journal:  Adv Funct Mater       Date:  2017-09-04       Impact factor: 18.808

8.  Transplantation of CD15-enriched murine neural stem cells increases total engraftment and shifts differentiation toward the oligodendrocyte lineage.

Authors:  Sushma Chaubey; John H Wolfe
Journal:  Stem Cells Transl Med       Date:  2013-05-16       Impact factor: 6.940

Review 9.  Regenerative cellular therapies for neurologic diseases.

Authors:  Michael Levy; Nicholas Boulis; Mahendra Rao; Clive N Svendsen
Journal:  Brain Res       Date:  2015-07-31       Impact factor: 3.252

Review 10.  The role of immune cells, glia and neurons in white and gray matter pathology in multiple sclerosis.

Authors:  Giulia Mallucci; Luca Peruzzotti-Jametti; Joshua D Bernstock; Stefano Pluchino
Journal:  Prog Neurobiol       Date:  2015-03-21       Impact factor: 11.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.